SS
IART icon

Steve Schonfeld’s Integra LifeSciences IART Stock Holding History

Steve Schonfeld’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,913
Closed -$185K – 2270
2025
Q3 		$185K Sell
12,913
-4,118
-24% -$56.4K ﹤0.01% 1956
2025
Q2 		$209K Buy
17,031
+4,521
+36% +$65.6K ﹤0.01% 1780
2025
Q1 		$275K Buy
+12,510
New +$294K ﹤0.01% 1827
2024
Q2 		– Sell
-10,683
Closed -$379K – 2335
2024
Q1 		$379K Sell
10,683
-15,874
-60% -$635K ﹤0.01% 1569
2023
Q4 		$1.16M Buy
+26,557
New +$1.05M 0.01% 981
2023
Q3 		– Sell
-63,762
Closed -$2.62M – 1993
2023
Q2 		$2.62M Buy
63,762
+58,526
+1,118% +$2.82M 0.02% 668
2023
Q1 		$301K Sell
5,236
-23,623
-82% -$1.33M ﹤0.01% 1375
2022
Q4 		$1.62M Sell
28,859
-87,480
-75% -$4.45M 0.01% 913
2022
Q3 		$4.93M Buy
116,339
+104,359
+871% +$5.35M 0.04% 530
2022
Q2 		$648K Sell
11,980
-24,620
-67% -$1.48M 0.01% 1224
2022
Q1 		$2.35M Buy
+36,600
New +$2.41M 0.02% 677
2021
Q2 		– Sell
-14,900
Closed -$1.03M – 2104
2021
Q1 		$1.03M Buy
+14,900
New +$1.01M 0.01% 884
2019
Q2 		– Sell
-8,280
Closed -$461K – 1104
2019
Q1 		$461K Buy
+8,280
New +$422K 0.02% 719
2017
Q2 		– Sell
-102,087
Closed -$4.3M – 682
2017
Q1 		$4.3M Buy
102,087
+31,465
+45% +$1.34M 0.43% 57
2016
Q4 		$3.03M Buy
+70,622
New +$2.87M 0.39% 67

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Steve Schonfeld's IART Position: Q4 2025 in Review

Steve Schonfeld sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 12,913 shares — an estimated $185K sold.

Steve Schonfeld first reported a position in IART in Q4 2016 and held it in 15 quarters. The position peaked at $4.93M in Q3 2022. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • Steve Schonfeld reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Steve Schonfeld sold 12,913 Integra LifeSciences shares in Q4 2025, an estimated $185K.
  • Steve Schonfeld first reported a position in Integra LifeSciences in Q4 2016 and held it in 15 quarters.
  • Steve Schonfeld's Integra LifeSciences position peaked at $4.93M in Q3 2022.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.